Natamicina versus voriconazol para queratitis fúngica

Retamal, J; Ordenes-Cavieres, G; Grau-Diez, A.
Medwave ; 18(8): e7387, 2018.
Artículo en Inglés, Español | LILACS | ID: biblio-969322

Documentos relacionados

  1. Mycotic Antimicrobial Localized Injection: A Randomized Clinical Trial Evaluating Intrastromal Injection of Voriconazole.
  2. Clinical and microbiological analysis of fungal keratitis in Toronto, Canada: A 20-year study.
  3. Continuous voriconazole lavage in managing moderate and severe fungal keratitis: a randomized controlled trial.
  4. [Experimental study of the effectiveness of terbinafine in the treatment of fungal keratitis].
  5. Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
  6. Fungal Keratitis Caused by Talaromyces coalescens: A Case Report.
  7. Therapeutic response time of topical voriconazole 1% and intrastromal voriconazole 0.05% versus topical natamycin 5% monotherapy in Fusarium keratitis in rabbit.
  8. Supradescemetic voriconazole injection for Candida parapsilosis keratitis.
  9. Clinical Profile and Treatment Outcomes of Patients With Acremonium Species Positive Keratitis Managed in a Tertiary Eye Care Center.
  10. Keratomycosis Caused by a Rare Pathogen, Myrothecium verrucaria.